Sam van Eeden, Medical Director NuaCell, a regenerative and functional medicine clinic, offers a turnkey solution, ‘Telomere Business in a Box,’ providing necessary materials, media, information, and doctor and staff training, enabling clinics to easily adopt telomere services. It has acquired invaluable experience by comprehensively exploring telomere services from scratch. Through a six to eight-month learning journey, the clinic identified a suitable laboratory capable of conducting the tests and established the necessary logistics, contracts, patient information and informational brochures.
The technology used for telomere testing, known as Quantitative Fluorescence in situ Hybridization (Q-FISH), is a patented technique approved by the FDA and the EU. Q-FISH offers a precise and accurate means of measuring telomeres, establishing itself as the gold standard for DNA analysis across all cell types.
"We can significantly expedite the process of introducing telomere services to clinics, drastically reducing the time and effort required," says Sam van Eeden, medical director of NuaCell.
The integration of telomere testing as a precision medicine tool fundamentally shifts the physicians' focus towards personalised treatments and empowers patients to take proactive roles in managing their health.
Upon receiving telomere test results, individuals are confronted with the reality of their biological age relative to chronological age. Patients gain insight into how their choices and medical interventions influence their telomere length and, consequently, their biological age, prompting them to re-evaluate their lifestyles and prioritise actions that promote a healthy lifespan and minimise diseases.
Telomere testing also enhances patients' understanding of the impact of external factors on DNA integrity, leading them to reassess their exposure to environmental toxins, radiation and other stressors that can accelerate ageing. This heightened awareness serves as a reality check, motivating patients to recognise the direct link between their choices and their overall health and lifespan.
It proves to be a vital tool for physicians in evaluating the efficacy of interventions in functional medicine. Unlike traditional biomarkers, which may exhibit fluctuations and offer limited insights into long-term health outcomes, telomere length is a reliable indicator of biological age. Previously, both patient and doctor faced challenges in objectively measuring the outcomes of various health interventions. Telomere testing now offers a reliable measure of progress, allowing patients and physicians to track improvements over time. Comparing pre- and post-intervention telomere lengths, physicians can assess the impact of treatments on biological ageing. This enables practitioners to gauge the effectiveness of interventions and provide patients with tangible evidence of improvement.
NuaCell's Telomere Business in a Box model simplifies the process for clinics interested in offering telomere services. Upon signing up, clinics receive test kits with unique identifiers for sample tracking, ensuring patient privacy in compliance with GDPR and HIPAA regulations. Detailed medical questionnaires accompany blood samples, providing comprehensive information for analysis. After sample collection, one of its logistical partners picks up the sealed and packaged samples for delivery to the laboratory. Approximately three weeks later, clinics receive a detailed report outlining telomere length measurements and providing insights into biological age relative to chronological age. The report includes graphs illustrating changes in telomere length over time, empowering individuals to monitor and improve their health.
The report provides insights into stimulating telomerase, an enzyme that repairs and lengthens telomeres, and advice on nutrition, habits and lifestyle changes to enhance overall well-being. This comprehensive approach enables individuals to make informed decisions about their health without necessarily requiring interpretation by a physician.
Inviting clinics worldwide to join the precision medicine revolution, NuaCell envisions a future where it assists them in making precision medicine a reality, leading to better measurable health outcomes.
Unlocking the Future of Regenerative Medicine with NuaCell: A Holistic Approach to Human Optimisation
Prof. Samuel van Eeden, MD, Chief Executive Officer
At NuaCell, we specialise in personalised regenerative medicine, offering innovative therapies such as NAD+ testing and Telomere Testing to enhance vitality, performance, and longevity, empowering individuals to achieve optimal health.
